New treatment for relapsed extensive-stage small cell lung cancer

View source ↗

Summary

The European Medicines Agency announces Imdylltra as a new treatment for relapsed extensive-stage small cell lung cancer, addressing an unmet need in patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Imdylltra

Snippet

Imdylltra addresses unmet need in people with poor prognosis and limited treatment options